Pregabalin demonstrated a higher response than Duloxetine treated group indicating better improvement from patient's point of viewFuture prospects: USFDA currently is considering the approval of Pregabalin as adjunctive therapy in adults with generalized anxiety disorder (GAD) or social anxiety disorder (SAD).
đang được dịch, vui lòng đợi..